Giro stage winner Ulissi tests positive for excessive amount of anti-asthma drug – road.cc


Reuters UK

Giro stage winner Ulissi tests positive for excessive amount of anti-asthma drug
road.cc
Lampre-Merida has revealed that Diego Ulissi, winner of two stages at last month's Giro d'Italia, has been notified by the UCI of an adverse analytical finding for an excessive amount of the anti-asthma drug salbutamol during the race. Both the rider
Diego Ulissi had 'abnormal' level of asthma drug in Giro d'ItaliaThe Guardian
Giro stage winner Ulissi fails drugs testSBS
Diego Ulissi fails anti-doping test from Giro d'ItaliaCycling Weekly
SkySports
all 17 news articles »

View full post on asthma – Google News

Diego Ulissi had ‘abnormal’ level of asthma drug in Giro d’Italia – The Guardian


Yahoo Eurosport UK

Diego Ulissi had 'abnormal' level of asthma drug in Giro d'Italia
The Guardian
Salbutamol is a medication used to treat asthma. The 24-year-old has been provisionally suspended by the team and requested the analysis of his B sample. “The athlete and the medical staff of the team will continue to explore the reasons why the urine
Giro stage winner Ulissi fails drugs testSBS
Diego Ulissi fails anti-doping test from Giro d'ItaliaCycling Weekly
Diego Ulissi temporarily suspended over 'abnormal' amount of salbutamol in testSkySports

all 15 news articles »

View full post on asthma – Google News

RusVelo withdraw from Giro dell’Appennino after asthma drug positives – Cyclingnews.com

RusVelo withdraw from Giro dell'Appennino after asthma drug positives
Cyclingnews.com
RusVelo has announced that it will not be on the start line for the Giro dell'Appennino on Sunday as a consequence of three of its riders testing positive for the asthma medication Fenoterol. The Professional Continental team is a member of the MPCC 
Rusvelo team confirms its withdrawal from Giro dell Appennino after trio of VeloNation

all 2 news articles »

View full post on asthma – Google News